Results 241 to 250 of about 874,138 (343)
Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases. [PDF]
Xian F +13 more
europepmc +1 more source
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Capsule robots for the monitoring, diagnosis, and treatment of intestinal diseases. [PDF]
Wei X +8 more
europepmc +1 more source
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth +19 more
wiley +1 more source
Machine learning-based diagnostic model for neonatal intestinal diseases in multiple centres: a cross-sectional study protocol. [PDF]
Zhao Q +9 more
europepmc +1 more source
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy +9 more
wiley +1 more source
Mechanisms of Insulin Signaling as a Potential Therapeutic Method in Intestinal Diseases. [PDF]
Jarmakiewicz-Czaja S +3 more
europepmc +1 more source

